Feasibility of reduced-intensity conditioning followed by unrelated cord blood transplantation for primary hemophagocytic lymphohistiocytosis: A nationwide retrospective analysis in Japan

International Journal of Hematology

Volumn 98, Issue 2, 2013, Pages 223-230

  Sawada, Akihisa ^a   Ohga, Shouichi ^b   Ishii, Eiichi ^c   Inoue, Masami ^a   Okada, Keiko ^d   Inagaki, Jiro ^e   Goto, Hiroaki ^f   Suzuki, Nobuhiro ^g   Koike, Kazutoshi ^h   Atsuta, Yoshiko ⁱ   Suzuki, Ritsuro ⁱ   Yabe, Hiromasa ^j   Kawa, Keisei ^a   Kato, Koji ^k   Yasutomo, Koji ^l  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d OSAKA CITY GENERAL HOSPITAL   (Japan)

^e National Hospital Organization   (Japan)

^f YOKOHAMA CITY UNIVERSITY   (Japan)

^g SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h Ibaraki Children's Hospital   (Japan)

ⁱ NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^l UNIVERSITY OF TOKUSHIMA   (Japan)

more..

Author keywords

Cord blood transplantation; FHL; Primary HLH; Reduced intensity conditioning

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; LYMPHOCYTE ANTIBODY; MELPHALAN; THYMOCYTE ANTIBODY;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BACTERIAL INFECTION; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CHILD; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE COURSE; EVENT FREE SURVIVAL; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT INFECTION; HEMOPHAGOCYTIC SYNDROME; HUMAN; INFANT; INTERSTITIAL PNEUMONIA; JAPAN; LEUKOCYTE COUNT; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MYELOABLATIVE CONDITIONING; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS INFECTION; WHOLE BODY RADIATION;

ADOLESCENT; ALLOGRAFTS; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; JAPAN; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MELPHALAN; MYELOABLATIVE AGONISTS; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; UNRELATED DONORS; VIDARABINE;

EID: 84882250333     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-013-1391-z     Document Type: Article

References (18)

1. Ishii E, Ohga S, Imashuku S, et al. Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences. Crit Rev Oncol Hematol. 2005;53:209-23.
2. Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124-31.
3. Henter JI, Samuelsson-Horne A, Aricò M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100:2367-73.
4. Shinagawa T, Tomita Y, Ishiguro H, et al. Final height and growth hormone secretion after bone marrow transplantation in children. Endocr J. 2001;48:133-8.
5. Marsh RA, Vaughn G, Kim MO, et al. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood. 2010;116:5824-31.
6. Ohga S, Kudo K, Ishii E, et al. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan. Pediatr Blood Cancer. 2010;54:299-306.
7. Bacigalupo A, Ballen K, Rizzo D, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15:1628-33.
8. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-55.
9. Landman-Parker J, Le Deist F, Blaise A, et al. Partial engraftment of donor bone marrow cells associated with long-term remission of haemophagocytic lymphohistiocytosis. Br J Haematol. 1983;85:37-41.
10. Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86:58-65.
11. Côte M, Ménager MM, Burgess A, et al. Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest. 2009;119:3765-73.
12. Horne A, Janka G, Maarten Egeler R, et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol. 2005;129:622-30.
13. Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62:738-44.
14. Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant. 1998;22:989-94.
15. Shimizu M, Sawada A, Yamada K, et al. Encouraging results of preserving ovarian function after allo-HSCT with RIC. Bone Marrow Transplant. 2012;47:141-2.
16. Brunstein CG, Weisdorf DJ, DeFor T, et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood. 2006;108:2874-80.
17. Blaes AH, Cao Q, Wagner JE, Young JA, Weisdorf DJ, Brunstein CG. Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2010;16:287-91.
18. Nishi M, Nishimura R, Suzuki N, et al. Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis. Am J Hematol. 2012;87:637-9.